USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE
USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE is a paper indexed in PICO Portal from OpenAlex.
How many citations does USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE have?
USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE has 0 citations in the OpenAlex counts PICO Portal stores.
When was USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE published?
USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE has 2022 year in the PICO Portal index.
What is the open-access status of USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE?
USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE has closed oa status in the PICO Portal index.
What is the DOI of USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE?
The DOI for USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE is on the source record.
What is the OpenAlex record for USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE?
The OpenAlex for USE OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATOLOGIC AND IMMUNE MEDIATED INFLAMMATORY DISEASE is on the source record.